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ABSTRAK
Salah satu dasar perawatan kritis adalah memberikan dukungan pada sistem respirasi yang memburuk. 
Terdapat 2 komponen utama dalam menangani gagal napas yaitu intervensi yang segera dan proses penyapihan. 
Banyak penelitian bertujuan untuk menentukan metode optimal ventilasi dan proses penyapihan dengan ventilasi 
noninvasif sebagai alternatif ventilasi invasif, pada berbagai penyebab gagal napas akut. Ventilasi noninvasif 
bertujuan untuk memberiikan dukungan ventilasi pada paru, tanpa intubasi trakea. Ventilasi noninvasif telah menjadi 
alat yang penting pada penanganan gagal napas akut. Ventilasi noninvasif positif telah mengalami evolusi yang 
luar biasa selama beberapa dekade terakhir dan diharapkan akan memegang peranan penting dalam menangani 
gagal napas baik akut dan juga kronis. Terjadi perbaikan dalam pertukaran gas, mengembalikan otot pernapasan 
yang mengalami kelelahan, dan perbaikan klinis dengan mengurangi morbiditas dan mortalitas. Namun demikian, 
kontraindikasi dan kegagalan perlu diidentifikasi secara jelas, sebab penundaan intubasi endotrakeal berkaitan 
dengan peningkatan morbiditas dan mortalitas. Selanjutnya, meskipun pemasangan intubasi dan ventilasi mekanik 
merupakan hal yang umum dilakukan, komplikasi dapat disebabkan oleh proses intubasi (kerusakan jaringan lokal) 
dan selama ventilasi mekanik (pneumonia dan sinusitis yang berkaitan dengan ventilator) akan memperpanjang 
masa rawat di perawatan intensif, lama rawat di rumah sakit dan meningkatkan mortalitas pada pasien tertentu.
Kata kunci: ventilasi noninvasif, ventilasi mekanik, gagal napas akut.
ABSTRACT
One of the cornerstones of critical care medicine is support of the failing respiratory system. The 2 major 
components of managing respiratory failure are the acute intervention and the weaning process. Many of the 
studies to determine the optimal methods of ventilation and weaning have focused on non-invasive positive-
pressure ventilation as an alternative to invasive ventilation, with various causes of acute respiratory failure. 
Non-invasive ventilation refers to the provision of ventilatory support to the lungs, without the use of an 
endotracheal airway. It has emerged as an important tool in the treatment of acute respiratory failure. Non-
invasive positive ventilation has undergone a remarkable evolution over the past decades and is assuming an 
important role in the management of both acute and chronic respiratory failure. There is improvement in gas 
exchange, relief of respiratory muscle fatigue, and clinical outcome with reduced morbidity and mortality. 
Nevertheless, contraindications and failures need to be identified early, as delaying endotracheal intubation 
is associated with increased morbidity and mortality. Furthermore, although it is common practice to give 
intubation and mechanical ventilation, complications can result from the intubation process (damage to local 
tissue) and during the course of ventilation (pneumonia and sinusitis associated with ventilators), prolonging 
stay in intensive care, length of hospital stay and mortality in selected patients.
Key words: non invasive ventilation, mechanical ventilation, acute respiratory failure.
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INTRODUCTION
One of the first descriptions of a “pulmonary 
plus pressure machine” in 1936 describes varying 
success in the treatment of cardiac asthma 
and bronchial asthma.1 Emergency physicians 
are often confronted with patients with acute 
respiratory failure. On occasion it is necessary 
to select therapeutic interventions, including 
a method of non-invasive ventilation (NIV), 
before a firm diagnosis is made.2 Non-invasive 
ventilation refers to the provision of ventilatory 
support through the patient’s upper airway using 
a mask or similar device. This technique is 
distinguished from those which bypass the upper 
airway with a tracheal tube, laryngeal mask, 
or tracheostomy and are therefore considered 
invasive.3 It has the advantage that it can be 
applied intermittently, avoids the need for 
sedation, and allows the patient to eat, drink and 
talk. The incidence of nosocomial pneumonia 
during NIV is lower than in intubated patients. 
Non-invasive ventilation has the additional 
advantage that it can be used with success outside 
the intensive care unit (ICU), thereby reducing 
the demand on ICU beds.4
However, NIV is not without its problems. The 
mask can be uncomfortable and claustrophobic 
for an acutely dyspnoeic patient. It can cause 
facial skin necrosis and, if poorly fitted, may be 
associated with large amounts of leakage which 
may compromise the efficiency of ventilation. 
Gastric distension is also recognised. Without 
the presence of an endotracheal/tracheostomy 
tube the lower airway cannot be easily accessed 
which makes bronchial toilet difficult. There has 
also been concern that NIV may delay intubation 
leading to a worse outcome. The ability to 
predict those likely to fail with NIV is important. 
Patients in whom there is a high likelihood of 
failure would be spared the discomfort of a trial 
of NIV and intubation would not be delayed. It 
would also be helpful in determining where NIV 
should take place; a patient with a high likelihood 
of failing, and for whom intubation would be 
considered appropriate, is best managed in the 
ICU, whereas the patient who is likely to be 
successfully treated with NIV can be managed 
on the ward.4
If ward based NIV is to be widely adopted 
into clinical practice, it would be useful to 
identify individuals who are likely to fail to 
respond to NIV either before or shortly after a 
trial of therapy. This will allow such patients to 
be managed in a higher dependency area or an 
ICU with ready access to invasive mechanical 
ventilation. The failure to do this may lead to a 
delay in intubation and an increase in mortality.5 
Despite overwhelming evidence to support its 
use, non-invasive positive pressure ventilation 
(NPPV) is underused. Residents and hospitalists 
need to identify NPPV as a treatment option in 
acute respiratory failure.6 This clinical review 
will address the use of non-invasive ventilation 
in acute respiratory failure, the evidence for its 
use in an emergency setting, and make some 
recommendations concerning its optimal use. 
In this document NIV refers to NPPV, and other 
less commonly used techniques such as external 
negative pressure or rocking beds will not be 
discussed.
RESPIRATORY FAILURE
Respiratory failure is defined as a failure 
to maintain adequate gas exchange and is 
characterised by abnormalities of arterial blood 
gas tensions. Type 1 failure is defined by a PaO2 
of <8 kPa (<60 mmHg) with a normal or low 
PaCO2. Type 2 failure is defined by a PaO2 of <8 
kPa (<60 mmHg) and a PaCO2 of >6 kPa (>50 
mmHg). Respiratory failure can be acute, acute-
on-chronic, or chronic. Although not always 
clearcut, this distinction is important in deciding 
on the location of patient treatment and the most 
appropriate treatment strategy, particularly in 
type 2 respiratory failure:3 a). Acute hypercapnic 
respiratory failure: the patient will have no, 
or minor, evidence of pre-existing respiratory 
disease and arterial blood gas tensions will show 
a high PaCO2, low pH, and normal bicarbonate. 
b). Chronic hypercapnic respiratory failure: 
evidence of chronic respiratory disease, high 
PaCO2, normal pH, high bicarbonate. c). Acute-
on-chronic hypercapnic respiratory failure: 
an acute deterioration in an individual with 
significant pre-existing hypercapnic respiratory 
failure, high PaCO2, low pH, high bicarbonate.
Acute Respiratory Failure can result from a 
variety of etiologies. It can result from primary 
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pulmonary pathologies or can be initiated by 
extra-pulmonary pathology with high mortality 
rate. Causes are often multifactorial. Acute 
respiratory failure can be caused by abnormalities 
in:6 a). Central Nervous System (drugs, metabolic 
encephalopathy, CNS infections, increased 
cranial pressure, obstructive sleep apnea, central 
alveolar hypoventilation); b). Spinal cord (trauma, 
transverse myelitis); c).  Neuromuscular system 
(polio, tetanus, Myasthenia gravis, Guillain-
Barre, critical care or steroid myopathy); 
d). Chest wall (Kyphoscoliosis, obesity); 
e). Upper airways (obstruction from tissue 
enlargement, infection, mass; vocal cord 
paralysis, tracheomalacia); f). Lower airways 
(bronchospasm, congestive heart failure, 
infection); g). Lung parenchyma (infection, 
interstitial lung disease); h). Cardiovascular 
system; i). Mediastinal mass, which Singh et al7 
reported has high mortality rate (100%).
Knowledge of arterial blood gases is 
essential before making a decision as to whether 
NIV is indicated. The patient should first be 
established on appropriate oxygen therapy and 
the arterial blood gases interpreted in light of 
the FiO2. A proportion of patients who fulfil 
arterial blood gas criteria for NIV at the time of 
admission to hospital may improve rapidly with 
initial medical treatment with an appropriate 
FiO2. It will usually then be necessary to repeat 
measurement of arterial blood gas tensions to see 
if NIV is still needed. Measurement of arterial 
blood gas tensions should be considered in all 
individuals with breathlessness of sufficient 
severity to warrant the use of NIV.3
NON-INVASIVE VENTILATION
Non-invasive ventilation via mouthpiece 
or mask (Figure 1) has been used to treat acute 
respiratory failure of several etiologies. The main 
goals are to improve gas exchange and reduce 
the work of breathing. Non-invasive ventilation 
may also prevent intubation and its potentially 
severe complications, such as pulmonary and 
upper-airway infection, which are associated 
with a higher mortality risk.8
Non-invasive positive pressure ventilation 
should, however, be considered as an alternative 
to invasive mechanical ventilation rather than 
its replacement. NIPPV cannot take over the 
use of invasive mechanical ventilation. Keys to 
the success of NPPV and to improving clinical 
outcomes of patients with acute respiratory 
failure are careful patient selection and a well 
designed clinical protocol because failure of 
NPPV only delays potentially more definitive 
therapy with invasive ventilation. Non-invasive 
positive pressure ventilation can be delivered 
using various types of ventilatory equipment 
and interfaces. Full-service ICU ventilators, 
portable bi-level pressure generators, and devices 
specifically designed to be used for NPPV are 
now available. The complete details of the 
application of NPPV are beyond the scope of this 
review, but virtually any ventilator, mode, and 
interface techniques may be used successfully. 
In Figure 2, Caples et al proposed a protocol 
used for CPAP and NIV used in acute respiratory 
failure.
Non-invasive positive pressure ventilation 
is used with patients with respiratory failure 
of various etiologies, but it should not be 
used with patients who have a low level of 
consciousness or noncompetent airway. A few 
studies have suggested that NPPV can be used 
for post-extubation ventilator weaning, and 
those studies found that NPPV reduces the need 
for re-intubation and sedation and reduces the 
occurrence of ventilator-associated pneumonia. 
NPPV remains controversial as a post-extubation 
technique, but NPPV trials have used only face 
mask or nasal mask, and some of the extubation 
failures in those trials might be attributable to 
Figure 1. Photograph of a patient treated with non-invasive 
ventilation.
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patient dissatisfaction with the masks.11
PATHOPHYSIOLOGICAL EFFECTS OF NON-
INVASIVE VENTILATION
Effects on the Respiratory System12
Extrinsically applied positive end expiratory 
pressure (ePEEP) increases alveolar size and 
recruitment. This expands the area available for 
gas exchange, reduces intrapulmonary shunt, 
improves lung compliance, and decreases the 
work of breathing. Extrinsically applied PEEP 
(ePEEP) acts to negate the effects of intrinsic 
PEEP (iPEEP), which is the cause of dynamic 
airway compression and gas trapping. Ventilation 
is improved with beneficial effects on the 
alveolararterial gradient, hypercarbia and, to a 
Respiratory Therapy Driven Protocol
For CPAP And NIV Use In Acute Respiratory Failure
I. Patient Evaluation
 Review history, diagnosis, inclusion, exclusion criteria and discuss with MD
 Ascertain whether new NIV use or an accustomedpatient
 Assess for component of chronic respiratory failure
II. Indications andGoals
 Choose as per patient diagnosis, level of distress, and whether ICU based
 Decide opt ions in event of early benefit or poor initial response
 Reaffirm code status and patient preferences regarding alternative therapy
III. Location
 Determine observation andmonitoring needs per patient conditionandequipment used (a step-downunit may be
appropriate for single organ failure or patients clear ly recovering from multi-organ failure).
IV. Equipment : Conditions, Initial Settings, and Targets
 Airflow generator
1. CPAP. Presumed obstructive sleep apnea or cardiogenic ARF for target of improved SpO2 and PaCO2
2. Portable Bi-Level Device. Acute on chronic component for target of improved PaCO2 and reduced dyspnea using
visual analog scale. Use with portable battery attachment for transporting patients.
3. ICU Bi-Level Device. Choose for patients in ICU, more severe distress in emergency department, or poor synchrony
and need for waveformmonitoring.
4. Full service ICU ventilator. Severely distressed patientswithpoor synchrony in considerationof pressure or volume
control modes
 Settings
1. CPAP. Set at 10-12,5 cmH2O and titrate as needed for OSA or dyspnea
2. Portable Bi-Level Device. Initial EPAP at minimum for neuromuscular disease patients. 5 cmH2O for others. May
increase EPAP for OSA component or for hypoxemia. Attention to auto-PEEP, which may be counteractedby
judicious use of EPAP. Initial IPAP at 8-10 cmH2O and target patient tolerance. Increase to 15-20 cmH20 as tolerance
allows for relief of dyspnea and respiratory rate.
3. ICU Bi-Level Device. Same EPAPand IPAP issues as for portable device but may need more aggressive titration as
situationdemands. Alter flow rate, sensitivity and inspiratory time tooptimize synchrony.
4. Full Service ICU Ventilator. Same issues as for ICU Bi-level device but may consider use of volume control and other
modes.
5. Oxygen. Guidedby distress level and SpO2. In those at risk of worsening hypercapnia on CPAP, maintain between
88%-90%
 Masks
1. Nasal.Utilize for less disstressed patients and those with chronic component. Also consider nasal pillows for more
claustrophobic patients
2. Full Face Mask. Patients with severe distress or large oral air leaks
V. Monitoring
 Oxymetry. All patients
 Arterial Blood Gases. Baseline and discharge ABG’s highly recommended. Useful for ICUpatients needing frequent
monitor ing of PaCO2.
 Ventilator with waveformmonitoring for poor synchrony problems
VI. Dismissal (Education and Communication)
 Anticipate early for patients with chronic component
 Review for diagnostic and reimbursment requirements
VII. NNV registry/oxymetry (recommended but not obligatory)
 Documentation. Log progress andoutcome for future patient use and protocol quality assessment.
*Reproduced from Gay, PC, Hubmayr, RD; “Mechanical ventilationpart II: noninvasive.” In Irwin and Rippe’s: Intensice Care Medicine
5th ed. 2003, p. 647-60
Figure 2. Respiratory therapy–driven protocol for continuous positive airway pressure (CPAP) and noninvasive ventilation 
(NIV) use in acute respiratory failure (ARF). ICU, intensive care unit; EPAP, expiratory positive airway pressure; PEEP, positive 
end-expiratory pressure; IPAP, inspiratory positive airway pressure; ABGs, arterial blood gases; OSA, obstructive sleep apnea; 
NNV, noninvasive nasal ventilation.10
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lesser extent, hypoxia. Pressure support (alone 
or as part of bilevel positive airway pressure, 
BiPAP) further augments alveolar ventilation 
and allows some respiratory muscle rest during 
the inspiratory phase.
Effects on the Cardiovascular System12
Positive end-expiratory pressure reduces 
venous return to the right side of the heart. 
Left ventricular preload, transmural pressure, 
and relative afterload are all decreased without 
altering myocardial contractility. Thus, the 
ejection fraction improves without an increase 
in myocardial oxygen consumption. It appears 
that those with worst ventricular dysfunction 
show the most significant improvement in 
stroke volume index with continuous positive 
airway pressure (CPAP). Overall, CPAP leads 
to a decrease in arterial pressure, heart rate, and 
rate-pressure product within 10 minutes, without 
exacerbation of hypotension.
Effects on Other Systems12
Intracranial pressure (ICP)—in patients with 
raised ICP there may be an increase in ICP by at 
least the same degree as the PEEP applied.
Renal—PEEP causes decreased sodium 
excretion and urine output, possibly due to raised 
vena caval pressure reducing cortical blood flow.
PATIENT SELECTION
As stated previously, the success of NPPV 
is critically dependent on careful patient 
selection. There is strong evidence that patients 
with COPD respond well to NPPV, particularly 
under certain conditions. Predictors of success 
include younger age, unimpaired consciousness, 
moderate rather than severe hypercarbia and 
acidemia, and prompt physiologic response 
(improvement in heart and respiratory rates 
and gas exchange within 2 hrs). Confalonieri 
et al. recently published a logistic regression 
model to predict failure of NPPV in patients 
with acute exacerbations of COPD. Based on 
1,033 consecutive COPD patients, of whom 
236 (22.8%) failed NPPV, the model showed the 
highest risk for failure occurred in those with a 
Glasgow coma scale of <11, pH <7.25, and a 
respiratory rate of >30 breaths/min.10 Based on 
the findings reported above, Caples and Gay10 
proposed an algorithm for NPPV and urge the 
use of established institutional protocols that are 
subjected to frequent reassessment (Figure 3).
Studies often emphasize disease indications 
and the initiation process for NPPV but are 
perhaps lacking in statements regarding response 
to failure and less appropriate use of NPPV. For 
this reason, careful discussion of the goals and 
preferences of the patient and practitioners before 
initiating NPPV treatment should be discussed. 
However, a “do not resuscitate or intubate (DNR/
DNI)” order should not itself preclude a trial of 
NPPV, which, as Levy et al. recently showed, 
can be associated with a favorable outcome in 
the setting of an acute event such as congestive 
heart failure or COPD exacerbation. In other 
settings of respiratory failure in DNR/DNI 
patients, NPPV may enhance patient comfort 
by reducing the work of breathing and may be 
appropriate for short-term use. However, fully 
informed consent should leave no ambiguity that 
NPPV could prolong a terminal event.10
SHOULD NON- INVASIVE POSIT IVE-
PRESSURE VENTILATION BE USED IN ALL 
FORMS OF ACUTE RESPIRATORY FAILURE?
Although NPPV has an established role 
as initial therapy in many forms of respiratory 
failure, it cannot be recommended for all 
patients in respiratory failure. In respiratory 
failure that develops soon after extubation, 
NPPV causes harm. But, if NPPV is used for 
patients who still at risk for respiratory failure 
after extubation, it can improve the outcomes 
of the patients. In the most severely ill patients 
with COPD or hypoxemic respiratory failure, 
NPPV is less likely to help. However, COPD 
or hypoxemic respiratory failure patients who 
have no contraindications to NPPV clearly 
shown improved outcome. In acute cardiogenic 
pulmonary edema, NPPV offers no advantage 
over simpler, less expensive interventions. In 
patients who require instantaneous ventilatory 
support or airway protection due to impaired 
consciousness, and for those who would interface 
poorly with the face mask, use of NPPV would 
be foolhardy. Clinical judgment, wisdom, and 
experience must still guide patient selection, 
but there probably remain many unrecognized 
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or unrealized opportunities to improve patient 
care with NPPV.13
PROBLEMS WITH NON-INVASIVE 
VENTILATION
Non-invasive ventilation appears to be 
probably free of serious complications and side 
effects. The primary disadvantage of non-invasive 
ventilation is its reliance on a spontaneously 
breathing patient who is able to protect their 
airway against the risk of aspiration. If either 
of these conditions are not met, endotracheal 
intubation and traditional ventilation is indicated. 
The most commonly reported complications 
of non-invasive ventilation are nasal bridge 
skin abrasions and patient intolerance of the 




Severe acidosis (pH <7,2)












If pt is DNI status, consider short
trial for acute heart failure/COPD;
Possible palliative therapy*








within 1-4 hours Consider intubation
initially or early if no
improvement
YES NO
Discussion with patient must include frank
explanation that NPPV should be considered
aggressive respiratory support that may not b e
consistent with patient with prior directives.  Each
patient situation requires addressing individual
specific wishes and needs as NPPV is also reasonable
as a palliative treatment
Figure 3. Noninvasive positive pressure ventilation (NPPV) for acute respiratory failure. COPD, chronic 
obstructive pulmonary disease; pt, patient; DNI, do not intubate; OSA, obstructive sleep apnea.10
frequently discussed side effect of non-invasive 
ventilation, but is relatively rarely described in 
clinical trial.
Non-invasive ventilatory systems are, 
generally, quite tolerant of leaks but mouth leaks 
with nasal masks can lead to therapeutic failure. 
Case reports exist of other complications of non-
invasive ventilation. A variety of arrhythmias 
(bradycardia, ventricular tachycardia, and 
ventricular standstill) have been reported during 
CPAP but were all probably related to underlying 
myocardial infarction. Pneumothorax is reported 
to have complicated treatment of Pneumocystis 
carinii pneumonia, but these patients are at 
high risk of this when ventilated by traditional 
means. Pneumocephalus has been described in 
one patient receiving CPAP after weaning from 
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traditional ventilation who had an unrecognised 
base of skull fracture as a result of a motor 
vehicle accident. One case of bilateral tympanic 
rupture and otorrhagia is reported in an agitated 
patient coughing against CPAP. Subconjunctival 
emphysema and corneal abrasions have also been 
reported.12
CONCLUSION
Endotracheal intubation and mechanical 
ventilation remain the preferred treatment in 
most cases of severe acute respiratory failure, 
especially if other systems are deranged at the 
same time. Continuous positive airway pressure 
provides relief of dyspnoea and an improvement 
in oxygenation in a proportion of patients, 
particularly those in whom hypoxaemia exists 
without hypercapnia. Non invasive positive 
pressure ventilation is feasible in patients with 
acute on chronic respiratory failure characterised 
by both hypoxaemia and hypercapnia in 
whom intubation is considered inappropriate, 
difficulties with weaning are anticipated, or 
long term ventilatory support might be needed. 
Admission to an intensive care unit can be 
avoided in some instances at least, and, if 
intubation does prove necessary, the technique 
may be useful as a means of helping the return 
of spontaneous breathing.14
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